128 related articles for article (PubMed ID: 8058587)
1. Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.
Sofia RD; Gordon R; Gels M; Diamantis W
Pharmacol Res; 1994; 29(2):139-44. PubMed ID: 8058587
[TBL] [Abstract][Full Text] [Related]
2. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182
[TBL] [Abstract][Full Text] [Related]
3. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
Palmer GC; Harris EW; Ray R; Stagnitto ML; Schmiesing RJ
Arch Int Pharmacodyn Ther; 1992; 317():16-34. PubMed ID: 1456842
[TBL] [Abstract][Full Text] [Related]
4. Selective antagonism of the anticonvulsant effects of felbamate by glycine.
Coffin V; Cohen-Williams M; Barnett A
Eur J Pharmacol; 1994 Apr; 256(2):R9-10. PubMed ID: 8050461
[TBL] [Abstract][Full Text] [Related]
5. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
[TBL] [Abstract][Full Text] [Related]
6. Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures.
Tomczyk T; Haberek G; Zuchora B; Jarosławska-Zych A; Kowalczyk MS; Wielosz M; Urbańska EM
Pharmacol Rep; 2007; 59(4):462-6. PubMed ID: 17901576
[TBL] [Abstract][Full Text] [Related]
7. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
Gordon R; Gels M; Wichmann J; Diamantis W; Sofia RD
Epilepsia; 1993; 34(2):367-71. PubMed ID: 8453946
[TBL] [Abstract][Full Text] [Related]
8. Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.
Kleckner NW; Glazewski JC; Chen CC; Moscrip TD
J Pharmacol Exp Ther; 1999 May; 289(2):886-94. PubMed ID: 10215667
[TBL] [Abstract][Full Text] [Related]
9. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit.
Harty TP; Rogawski MA
Epilepsy Res; 2000 Mar; 39(1):47-55. PubMed ID: 10690753
[TBL] [Abstract][Full Text] [Related]
10. Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.
De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A
Pharmacol Biochem Behav; 1996 Oct; 55(2):281-7. PubMed ID: 8951966
[TBL] [Abstract][Full Text] [Related]
11. Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration.
Taylor LA; McQuade RD; Tice MA
Eur J Pharmacol; 1995 Apr; 289(2):229-33. PubMed ID: 7621896
[TBL] [Abstract][Full Text] [Related]
12. Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice.
Gordon R; Gels M; Diamantis W; Sofia RD
Pharmacol Biochem Behav; 1991 Sep; 40(1):109-13. PubMed ID: 1664105
[TBL] [Abstract][Full Text] [Related]
13. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor".
Rogawski MA; Wasterlain CG; Mazarati AM
Epilepsia; 2000 Jul; 41(7):918-9. PubMed ID: 10897169
[No Abstract] [Full Text] [Related]
14. Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants.
Moreau JL; Pieri L; Prud'hon B
Br J Pharmacol; 1989 Nov; 98(3):1050-4. PubMed ID: 2574061
[TBL] [Abstract][Full Text] [Related]
15. Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat.
Sofia RD; Gordon R; Gels M; Diamantis W
Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):335-41. PubMed ID: 8480078
[TBL] [Abstract][Full Text] [Related]
16. Felbamate block of the N-methyl-D-aspartate receptor.
Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
[TBL] [Abstract][Full Text] [Related]
17. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
Witkin JM; Gasior M; Heifets B; Tortella FC
J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
[TBL] [Abstract][Full Text] [Related]
18. Effects of felbamate, kynurenic acid derivatives and NMDA antagonists on in vitro kainate-induced epileptiform activity.
Domenici MR; Marinelli S; Sagratella S
Life Sci; 1996 May; 58(26):PL391-6. PubMed ID: 8691980
[TBL] [Abstract][Full Text] [Related]
19. Felbamate demonstrates low propensity for interaction with methylxanthines and Ca2+ channel modulators against experimental seizures in mice.
Gasior M; Swiader M; Przybyłko M; Borowicz K; Turski WA; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1998 Jul; 352(2-3):207-14. PubMed ID: 9716356
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
Rho JM; Donevan SD; Rogawski MA
Ann Neurol; 1994 Feb; 35(2):229-34. PubMed ID: 8109904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
